Platinum Based Doublet | List of Frontiers open access articles

Original Research

Published on 11 Nov 2025

Efficacy and prognostic analysis of chemo-immunotherapy after TKI resistance in EGFR-mutant non-small cell lung cancer with TP53 or KRAS co-mutations

in Cancer Immunity and Immunotherapy

Yuhui Nie
Chen Song
Kun Wu
Mingxin Yu
Jia Hu
Shuzhen Liu
Fu Hui

Frontiers in Immunology

doi 10.3389/fimmu.2025.1684089

2,088 views
1 citation

Original Research

Published on 02 May 2025

Cost-effectiveness of atezolizumab versus chemotherapy in patients with non-small-cell lung cancer ineligible for platinum-based doublet chemotherapy

in Health Economics

Qiuji Wu
Yi Qin
Qiu Li

Frontiers in Public Health

doi 10.3389/fpubh.2025.1349645

3,685 views
2 citations

Original Research

Published on 11 Feb 2021

nab-Paclitaxel Plus Durvalumab in Patients With Previously Treated Advanced Stage Non-small Cell Lung Cancer (ABOUND.2L+)

in Thoracic Oncology

Daniel Morgensztern
Manuel Cobo Dols
Santiago Ponce Aix
Pieter E. Postmus
Jaafar Bennouna
Jürgen R. Fischer
Oscar Juan-Vidal
David J. Stewart
Andrea Ardizzoni
Rafia Bhore

Frontiers in Oncology

doi 10.3389/fonc.2020.569715

6,369 views
4 citations

Original Research

Published on 24 Nov 2025

Neoadjuvant chemotherapy versus surgery alone in locally advanced esophageal squamous cell carcinoma: a propensity-matched real-world study

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Yuchen Wang
Zhifeng Yue
Zhifeng Li
Jin Yang
Jifang Yao
Junfeng Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1691998

805 views

Systematic Review

Published on 28 Jul 2025

Cost-effectiveness of chemotherapy for advanced and recurrent cervical cancer: a systematic review

in Health System Economics and Financing

Katsuaki Inami

Frontiers in Health Services

doi 10.3389/frhs.2025.1616223

4,282 views

Original Research

Published on 07 May 2021

Pemetrexed-Platinum With or Without Bevacizumab for Chinese Chemo-Naive Advanced Lung Adenocarcinoma Patients: A Real-World Study

in Pharmacology of Anti-Cancer Drugs

Xin Li
Jie Huang
Yao Qiu
Qianyun Zhang
Shaoyu Yang
Kan Wu
Jiaoli Wang
Limin Wang
Jian Ye
Shenglin Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2021.649222

4,657 views
4 citations

Case Report

Published on 11 Jan 2024

Sinus metastasis of lung adenocarcinoma: a case report

in Pulmonary Medicine

Mingyuan Xu
Qi Sun
Xin Lv
Fangjun Chen
Shu Su
Lifeng Wang

Frontiers in Medicine

doi 10.3389/fmed.2023.1323222

2,893 views
2 citations

Review

Published on 19 Sep 2017

Radiotherapy for Oligometastatic Lung Cancer

in Radiation Oncology

Derek P. Bergsma
Joseph K. Salama
Deepinder P. Singh
Steven J. Chmura
Michael T. Milano

Frontiers in Oncology

doi 10.3389/fonc.2017.00210

13,789 views
56 citations

Systematic Review

Published on 13 Apr 2021

First-Generation EGFR-TKI Plus Chemotherapy Versus EGFR-TKI Alone as First-Line Treatment in Advanced NSCLC With EGFR Activating Mutation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

in Thoracic Oncology

Qiang Wu
Wuxia Luo
Wen Li
Ting Wang
Lin Huang
Feng Xu

Frontiers in Oncology

doi 10.3389/fonc.2021.598265

10,286 views
42 citations

Original Research

Published on 21 Oct 2024

A real-world retrospective study to assess efficacy and safety of alectinib as adjuvant therapy in IB-IIIB NSCLC patients harboring ALK rearrangement

in Thoracic Oncology

Zeng-Hao Chang
Teng-Fei Zhu
Wei Ou
Hao Jiang
Si-Yu Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1422035

3,942 views
5 citations

Articles

Efficacy and prognostic analysis of chemo-immunotherapy after TKI resistance in EGFR-mutant non-small cell lung cancer with TP53 or KRAS co-mutations

Cost-effectiveness of atezolizumab versus chemotherapy in patients with non-small-cell lung cancer ineligible for platinum-based doublet chemotherapy

nab-Paclitaxel Plus Durvalumab in Patients With Previously Treated Advanced Stage Non-small Cell Lung Cancer (ABOUND.2L+)

Neoadjuvant chemotherapy versus surgery alone in locally advanced esophageal squamous cell carcinoma: a propensity-matched real-world study

Cost-effectiveness of chemotherapy for advanced and recurrent cervical cancer: a systematic review

Pemetrexed-Platinum With or Without Bevacizumab for Chinese Chemo-Naive Advanced Lung Adenocarcinoma Patients: A Real-World Study

Sinus metastasis of lung adenocarcinoma: a case report

Radiotherapy for Oligometastatic Lung Cancer

First-Generation EGFR-TKI Plus Chemotherapy Versus EGFR-TKI Alone as First-Line Treatment in Advanced NSCLC With EGFR Activating Mutation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

A real-world retrospective study to assess efficacy and safety of alectinib as adjuvant therapy in IB-IIIB NSCLC patients harboring ALK rearrangement